vs

Side-by-side financial comparison of Lion Group Holding Ltd (LGHL) and SUTRO BIOPHARMA, INC. (STRO). Click either name above to swap in a different company.

Lion Group Holding Ltd is the larger business by last-quarter revenue ($13.3M vs $11.6M, roughly 1.1× SUTRO BIOPHARMA, INC.).

LION is a Canadian electric vehicle manufacturer headquartered in Saint-Jérôme, Quebec. Founded in 2011 as Lion Bus, the company is primarily known for its production of yellow school buses, of which it was the first to mass produce as a fully electric vehicle.

Sutro Biopharma, Inc. is a publicly traded biotechnology company headquartered in South San Francisco, California focused on clinical-stage drug discovery, development and manufacturing. Using a proprietary cell-free protein synthesis platform, Sutro is working on oncology therapeutics using protein engineering and rational design. Founded in 2003 under the name Fundamental Applied Biology, the company name changed to Sutro Biopharma in 2009. William Newell, CEO as of 2024, joined Sutro in Ja...

LGHL vs STRO — Head-to-Head

Bigger by revenue
LGHL
LGHL
1.1× larger
LGHL
$13.3M
$11.6M
STRO

Income Statement — Q2 FY2024 vs Q4 FY2025

Metric
LGHL
LGHL
STRO
STRO
Revenue
$13.3M
$11.6M
Net Profit
$-53.7K
Gross Margin
Operating Margin
Net Margin
-0.4%
Revenue YoY
-21.4%
Net Profit YoY
35.4%
EPS (diluted)

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
LGHL
LGHL
STRO
STRO
Q4 25
$11.6M
Q3 25
$9.7M
Q2 25
$63.7M
Q1 25
$17.4M
Q4 24
$14.8M
Q3 24
$8.5M
Q2 24
$13.3M
$25.7M
Q1 24
$13.0M
Net Profit
LGHL
LGHL
STRO
STRO
Q4 25
Q3 25
$-56.9M
Q2 25
$-11.5M
Q1 25
$-76.0M
Q4 24
$-72.4M
Q3 24
$-48.8M
Q2 24
$-53.7K
$-48.0M
Q1 24
$-58.2M
Operating Margin
LGHL
LGHL
STRO
STRO
Q4 25
Q3 25
-499.9%
Q2 25
-5.2%
Q1 25
-393.8%
Q4 24
-440.7%
Q3 24
-797.2%
Q2 24
-189.4%
Q1 24
-435.0%
Net Margin
LGHL
LGHL
STRO
STRO
Q4 25
Q3 25
-586.6%
Q2 25
-18.0%
Q1 25
-436.6%
Q4 24
-489.2%
Q3 24
-572.6%
Q2 24
-0.4%
-186.8%
Q1 24
-447.5%
EPS (diluted)
LGHL
LGHL
STRO
STRO
Q4 25
Q3 25
$-0.67
Q2 25
$-0.14
Q1 25
$-0.91
Q4 24
$-27.63
Q3 24
$-0.59
Q2 24
$-0.59
Q1 24
$-0.59

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
LGHL
LGHL
STRO
STRO
Cash + ST InvestmentsLiquidity on hand
$29.0M
$141.4M
Total DebtLower is stronger
Stockholders' EquityBook value
$28.4M
$-132.5M
Total Assets
$74.5M
$173.8M
Debt / EquityLower = less leverage

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
LGHL
LGHL
STRO
STRO
Q4 25
$141.4M
Q3 25
$167.6M
Q2 25
$205.1M
Q1 25
$249.0M
Q4 24
$316.9M
Q3 24
$388.3M
Q2 24
$29.0M
$375.6M
Q1 24
$267.6M
Stockholders' Equity
LGHL
LGHL
STRO
STRO
Q4 25
$-132.5M
Q3 25
$-87.3M
Q2 25
$-32.1M
Q1 25
$-25.8M
Q4 24
$44.6M
Q3 24
$111.2M
Q2 24
$28.4M
$152.2M
Q1 24
$98.0M
Total Assets
LGHL
LGHL
STRO
STRO
Q4 25
$173.8M
Q3 25
$209.7M
Q2 25
$262.4M
Q1 25
$321.4M
Q4 24
$387.2M
Q3 24
$451.8M
Q2 24
$74.5M
$489.0M
Q1 24
$403.4M

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
LGHL
LGHL
STRO
STRO
Operating Cash FlowLast quarter
$-177.2M
Free Cash FlowOCF − Capex
FCF MarginFCF / Revenue
Capex IntensityCapex / Revenue
Cash ConversionOCF / Net Profit
TTM Free Cash FlowTrailing 4 quarters

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
LGHL
LGHL
STRO
STRO
Q4 25
$-177.2M
Q3 25
$-38.2M
Q2 25
$-44.7M
Q1 25
$-67.9M
Q4 24
$-71.7M
Q3 24
$-64.5M
Q2 24
$9.5M
Q1 24
$-64.7M

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

LGHL
LGHL

Trading gains$7.8M59%
Other$2.4M18%
Securities brokerage commissions and fees$1.7M13%
Market making commissions and fees$1.0M8%
Other income$380.2K3%

STRO
STRO

Segment breakdown not available.

Related Comparisons